SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

The RAGE community is driving momentum for their token by positioning it as a nostalgic, culture-defining meme that honors early 2000s internet history. Holders are actively engaged in daily "bag working" and comic creation through their restored web platforms, emphasizing conviction in the project's long-term growth as an OG alternative to newer, forced meme coins.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4CHAN continues to trend as a 'meme factory' index, with community members framing it as the foundational 'source code' for internet culture and the primary hedge against broader market volatility. Investors are actively discussing the accumulation of quad-trillion holdings to capitalize on potential price appreciation while debating the project's long-term utility versus its speculative nature.

The TROLL token on the Solana network is a meme coin inspired by internet trolling culture, designed for entertainment and community engagement with no intrinsic value. Built on Solana’s blockchain, it leverages the network’s fast transactions and low fees to appeal to meme enthusiasts. Launched on decentralized exchanges, TROLL aims to foster a fun, community-driven ecosystem through social media, influencer partnerships, and viral marketing, embodying the playful spirit of online trolling.

Troll

Troll (TROLL) is trending as the community highlights its status as an 'OG' meme coin rooted in classic internet culture, with many holders advocating for it as a long-term hold alongside other community-driven projects. Investors are actively discussing potential upside based on its historical performance and its role as a representative of nostalgic web culture.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as investors aggressively accumulate shares ahead of a series of pivotal Phase 3 data readouts expected throughout 2026, which the community views as a potential make-or-break moment for the company's retinal disease pipeline. While the stock has seen significant volatility, sentiment is currently driven by institutional interest and bullish technical setups, with many participants actively debating whether the company's recent pipeline de-risking and cash runway are sufficient to fuel a long-term recovery to previous valuation levels.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph (HBAR) is currently trending as investors discuss its strong enterprise partnerships, such as the recent FedEx collaboration, and speculate on the impact of upcoming US regulatory clarity via the Clarity Act. The community remains divided between long-term holders highlighting HBAR's thermodynamic efficiency and institutional utility, and traders frustrated by ongoing price consolidation and historical token dilution.

iShares Trust - iShares 0-3 Month Treasury Bond ETF

iShares 0-3 Month Treasury Bond ETF

Investors are increasingly flocking to SGOV as a safe-haven parking spot for cash, driven by its stability and monthly dividend payouts amid ongoing concerns regarding market volatility and economic uncertainty. The community views the ETF as a defensive alternative to equities, frequently discussing it as a low-risk strategy to protect capital while waiting for clearer market signals or potential corrections.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks ($PANW) is facing intense selling pressure as investors react to a weaker profit outlook despite solid revenue performance, fueling broader market concerns about AI's potential to disrupt traditional cybersecurity business models. The community is deeply divided between long-term holders viewing the pullback as a prime accumulation opportunity for an essential platform player and skeptics who are bracing for further downside amid integration costs and valuation concerns.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup is currently in the spotlight as investors react to a significant reversal in regulatory capital requirements, which are now expected to be less stringent than previously proposed. This development has triggered active community discussion regarding the bank's long-term capital allocation, potential for increased shareholder returns, and the broader implications for the banking sector's profitability.

Patterson-UTI Energy, Inc. engages in the provision of drilling and pressure pumping services, directional drilling, rental equipment, and technology. It operates through the following segments: Drilling Services, Completion Services, and Drilling Products. The Drilling Services segment represents contract drilling, directional drilling, oilfield technology, and electrical controls and automation businesses. The Completion Services segment offers hydraulic fracturing, wireline and pumping, completion support, cementing, and pressure pumping business. The Drilling Products segment focuses on manufacturing and distribution of drill bits business. The company was founded by Cloyce A. Talbott and A. Glenn Patterson in 1978 and is headquartered in Houston, TX.

Patterson-UTI Energy Inc

Patterson-UTI Energy is trending as investors monitor ongoing supply and demand dynamics in the U.S. oil patch, with the community actively debating the company's growth potential amid geopolitical volatility and broader energy sector consolidation.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is currently facing intense scrutiny as shareholders debate the company's long-term viability amid concerns over cash burn and leadership performance. The community is actively tracking potential clinical trial readouts while navigating volatile trading patterns and skepticism regarding the effectiveness of existing management in creating shareholder value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?

Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy...

HC Wainwright Estimates Pharming Group Q3 Earnings

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Free Report) - Investment analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for shares of Pharming Group in a report...

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Sees Significant Growth in Short Interest

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 27th, there was short interest totaling...

Pharming Group (NASDAQ:PHAR) Earns "Outperform" Rating from Oppenheimer

Oppenheimer reissued an "outperform" rating and set a $41.00 target price (down from $42.00) on shares of Pharming Group in a research note on Friday...

HC Wainwright Predicts Pharming Group Q1 Earnings

Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Free Report) - HC Wainwright issued their Q1 2026 earnings per share estimates for Pharming Group in a research report issued on Thursday, March 12th...

Pharming Group (NASDAQ:PHAR) Posts Earnings Results, Misses Estimates By $0.08 EPS

Pharming Group (NASDAQ:PHAR - Get Free Report) posted its quarterly earnings results on Thursday. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate...

Pharming Group Q4 Earnings Call Highlights

Pharming Group (NASDAQ:PHAR) reported what management described as a strong finish to 2025, highlighting double-digit revenue growth, a return to operating profitability, and expanding commercial...

Pharming Group (OTCMKTS:PHGUF) Shares Gap Down - Here's What Happened

Pharming Group (OTCMKTS:PHGUF) Shares Gap Down - Here's Why...

Pharming Group (PHAR) to Release Earnings on Thursday

Pharming Group (NASDAQ:PHAR) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 12. (View Earnings Report at...

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

PHAR heads into Q4 results, with Ruconest and Joenja sales in focus, pipeline updates looming, and investors eyeing clarity on key regulatory setbacks.

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

PHAR
Pharming Group

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PHAR News

PHARPharming Group